Specialty Drug Usage Highlights SPT Week in Review

5. An HIV Cure May Need a Different Approach From Immune Control Treatments

Patients with HIV on ART may have high viral levels, immune activation, and inflammation.

https://www.specialtypharmacytimes.com/news/an-hiv-cure-may-need-a-different-approach-from-immune-control-treatments

4. Safety Concerns Arise in Thirty-Two Percent of Drugs After Receiving FDA Approval

Findings highlight the need for continuous safety monitoring of novel therapeutics.

https://www.specialtypharmacytimes.com/news/safety-concerns-arise-in-thirty-two-percent-of-drugs-after-receiving-fda-approval

3. Branded Drug Price Increases Outpace Specialty Drugs

The cost of branded, specialty, and generic drugs increased 8.77% in 2016.

https://www.specialtypharmacytimes.com/news/branded-drug-price-increases-outpace-specialty-drugs

2. Big Pharma's Biosimilar Stalling Tactics Coming to an End

The current outlook for biosimilar manufacturers shows significant promise.

https://www.specialtypharmacytimes.com/news/big-pharmas-biosimilar-stalling-tactics-coming-to-an-end

1. The Misaligned Uses for Specialty Pharmacy Drugs

The use of specialty drugs for weight loss, building muscle mass, or for cosmetic purposes carries risky implications.

https://www.specialtypharmacytimes.com/news/the-misaligned-uses-for-specialty-pharmacy-drugs